Chronic Treatment with Desipramine Improves Cognitive Performance of Rats in an Attentional Set-Shifting Test
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Alterations in central monoaminergic neurotransmission are important in the actions of many antidepressants. This study tested the hypothesis that tonic elevation of noradrenergic (NA) neurotransmission in medial prefrontal cortex (mPFC) by chronic treatment with the selective norepinephrine (NE) reuptake blocker desipramine (DMI) may contribute to the beneficial cognitive effects of this antidepressant drug (AD). Male Sprague-Dawley rats were treated with DMI acutely (15 mg/kg, i.p.) or chronically for 21 days (7.5 mg/kg/day via osmotic minipump) before assessing performance on an attentional set-shifting test. The extradimensional set-shifting component of this test reflects a process of cognitive flexibility that is dependent upon mPFC, and that we have shown previously to be facilitated by NA activity in mPFC. Microdialysis was performed to measure NE release in mPFC concurrently with behavioral testing. Acute DMI treatment produced an increase in extracellular NE levels in mPFC, and a modest improvement in overall performance across all task stages of the attentional set-shifting test, but failed to produce a significant improvement in any of the individual specific tasks comprising the test sequence. Chronic DMI treatment tonically elevated basal extracellular NE levels in mPFC, associated with a significant improvement in performance specifically on the extradimensional set-shifting component of the test. There was also a significant reduction in set loss errors in rats treated chronically with DMI. Hence, tonic elevation of NA transmission in mPFC by chronic DMI treatment was associated with a time-dependent facilitation of cognitive flexibility that may contribute to the mechanism whereby chronic treatment with ADs, specifically NE reuptake blockers, may exert a beneficial therapeutic effect on cognition in depressed patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, acute and chronic administration of the norepinephrine reuptake inhibitor desipramine (DMI) improved reversal learning in naïve rats, in both the AST (Lapiz et al 2007) and a four-position operant discrimination test (Seu & Jentsch 2009, Seu et al 2009).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Lapiz et al 2007
In the citing paper
“chronic treatment with desipramine, a selective norepinephrine reuptake blocker, increases tonic noradrenergic transmission in the mPFC”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Lapiz et al 2007
In the citing paper
“enhances performance on the ED task (Lapiz et al 2007).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Lapiz et al 2007
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 1×
“A guide cannula (CMA/12; CMA Microdialysis, North Chelmsford, MA), aimed at the mPFC, was implanted using a 101 lateral approach with the following coordinates relative to bregma: AP + 2.6 mm, ML + 1.4 mm, DV 1.7 mm, based on the atlas of Paxinos and Watson (1998).”
Influential(1975) · Medical Entomology and Zoology · Cited by 7,245
Cognitive Therapy and the Emotional Disorders
Ince, L. P. (1977) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1977.31.4.633 · Cited by 2,892
Wisconsin Card Sorting Test manual
Heaton, R. K. (1981) · Medical Entomology and Zoology · Cited by 2,602
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831 · cited 1×
“It was suggested in that paper that the increase in dopamine may have been attributable to a possible shift in the firing pattern of dopaminergic neurons from a tonic to a bursting mode of activity (see Gonon, 1988; Grace, 1991).”
BackgroundMedial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat
Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421 · cited 11×
“In primates, the medial prefrontal cortex (mPFC) mediates the ability to shift attention between perceptual features of complex stimuli (Dias et al, 1996, 1997; Owen et al, 1991), and in rats, it has been implicated specifically in attentional set-shifting, or the ability to ‘unlearn’ an established contingency in ord…”
BackgroundMethodResultInfluentialPrefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · cited 2×
“…in the ability to attend to changes in the environment and adapt behavioral response strategies accordingly, that is, behavioral flexibility (Dalley et al, 2004; Ragozzino et al, 1999), and several tests have been developed to measure this cognitive ability in both humans and animals…”
BackgroundCurrent advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113
Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., & Mayberg, H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.34 · Cited by 1,068 · cited 1×
“Treatment with cognitive behavioral therapy or AD drugs such as paroxetine produced changes in prefrontal cortical function, also revealed by functional neuroimaging (Goldapple et al, 2004; Kennedy et al, 2001; Prasko et al, 2004).”
BackgroundThe psychology of depression: Contemporary theory and research
(1975) · Behavior Therapy · doi:10.1016/s0005-7894(75)80166-3 · Cited by 972
Role of locus coeruleus in attention and behavioral flexibility
Aston-Jones, G., Rajkowski, J., & Cohen, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00140-7 · Cited by 900 · cited 4×
“At higher levels of tonic NA activity, response accuracy was reduced, and phasic activation of NA neurons by target stimuli was masked by the higher levels of tonic activity (Aston-Jones et al, 1994, 1999, 2000).”
BackgroundMethodInfluentialA cognitive model of selective processing in anxiety
Mathews, A., & Mackintosh, B. (1998) · Cognitive Therapy and Research · doi:10.1023/a:1018738019346 · Cited by 756 · cited 3×
“It is increasingly recognized that in addition to mood symptoms, cognitive dysfunction is also a major component of depression and anxiety disorders, and may in fact underlie many of the affective symptoms (Anisman and Matheson, 2005; Beck, 1976; Coles and Heimberg, 2002; Mathews and Mackintosh, 1998).”
BackgroundKennedy, S. H., Evans, K. R., Krüger, S., Mayberg, H. S., Meyer, J. H., McCann, S., Arifuzzman, A. I., Houle, S., & Vaccarino, F. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.899 · Cited by 710 · cited 1×
“Treatment with cognitive behavioral therapy or AD drugs such as paroxetine produced changes in prefrontal cortical function, also revealed by functional neuroimaging (Goldapple et al, 2004; Kennedy et al, 2001; Prasko et al, 2004).”
BackgroundDifferentiating anxiety and depression: A test of the cognitive content-specificity hypothesis.
Beck, A. T., Brown, G. P., Steer, R. A., & Eidelson, J. I. (1987) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.96.3.179 · Cited by 706 · cited 1×
“It has been increasingly recognized that, in addition to mood symptoms, cognitive dysfunction is a major component of depression and anxiety disorders, and may in fact underlie some of the affective symptoms (Beck, 1976; Beck et al, 1987; Coles and Heimberg, 2002; Mathews and Mackintosh, 1998).”
BackgroundGonon, F. G. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90307-7 · Cited by 676 · cited 1×
“It was suggested in that paper that the increase in dopamine may have been attributable to a possible shift in the firing pattern of dopaminergic neurons from a tonic to a bursting mode of activity (see Gonon, 1988; Grace, 1991).”
BackgroundNeuroimaging studies of mood disorder effects on the brain
Sheline, Y. I. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00347-0 · Cited by 660 · cited 1×
“Imaging studies have shown associations between cognitive dysfunction and altered activity in prefrontal cortex in depression (Rogers et al, 2004; Sheline, 2003).”
BackgroundEmotional bias and inhibitory control processes in mania and depression
MURPHY, F. C., SAHAKIAN, B. J., RUBINSZTEIN, J. S., MICHAEL, A., ROGERS, R. D., ROBBINS, T. W., & PAYKEL, E. S. (1999) · Psychological Medicine · doi:10.1017/s0033291799001233 · Cited by 659 · cited 3×
“This is consistent with the perseverative attention to themes of loss and worthlessness and the persistent ruminations that are prevalent in this disorder (Murphy et al, 1999, 2003).”
BackgroundInfluentialOwen, A. M., Roberts, A. C., Polkey, C. E., Sahakian, B. J., & Robbins, T. W. (1991) · Neuropsychologia · doi:10.1016/0028-3932(91)90063-e · Cited by 657 · cited 1×
“…the medial prefrontal cortex (mPFC) mediates the ability to shift attention between perceptual features of complex stimuli (Dias et al, 1996, 1997; Owen et al, 1991), and in rats, it has been implicated specifically in attentional set-shifting, or the ability to ‘unlearn’ an established…”
BackgroundLocus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task
Aston-Jones, G., Rajkowski, J., Kubiak, P., & Alexinsky, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04467.1994 · Cited by 637 · cited 2×
“At higher levels of tonic NA activity, response accuracy was reduced, and phasic activation of NA neurons by target stimuli was masked by the higher levels of tonic activity (Aston-Jones et al, 1994, 1999, 2000).”
BackgroundMethodThe Psychology of Depression: Contemporary Theory and Research
KRAINES, S. H. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.4.467 · Cited by 620
Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat
McAlonan, K., & Brown, V. J. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.019 · Cited by 618 · cited 1×
“The difficulty of this task is reflected in the consistently higher number of trials required to reach criterion, evident both in this study and in previous studies (Birrell and Brown, 2000; Lapiz and Morilak, 2006; McAlonan and Brown, 2003; Tunbridge et al, 2004).”
ResultStuss, D. T., Levine, B., Alexander, M. P., Hong, J., Palumbo, C., Hamer, L., Murphy, K. J., & Izukawa, D. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00093-7 · Cited by 596 · cited 2×
“In addition, we also analyzed the occurrence of set loss errors, a measure adapted from the analysis of errors on the WCST as described by Stuss et al (1983, 2000).”
MethodResultAston-Jones, G., Chiang, C., & Alexinsky, T. (1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)63830-3 · Cited by 589 · cited 2×
“…modulatory influence that facilitates a variety of autonomic, neuroendocrine, cognitive, and behavioral processes, which in turn may contribute to behavioral state changes such as increased arousal, or to adaptive responses to acute stress (Aston-Jones et al, 1991, 1999, 2000; Morilak et al, 2005).”
BackgroundRole of brain norepinephrine in the behavioral response to stress
Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., & Petre, C. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.007 · Cited by 570 · cited 1×
“…modulatory influence that facilitates a variety of autonomic, neuroendocrine, cognitive, and behavioral processes, which in turn may contribute to behavioral state changes such as increased arousal, or to adaptive responses to acute stress (Aston-Jones et al, 1991, 1999, 2000; Morilak et al, 2005).”
BackgroundSelf-citationStress, depression, and anhedonia: caveats concerning animal models
Anisman, H., & Matheson, K. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.007 · Cited by 569 · cited 2×
“It is increasingly recognized that in addition to mood symptoms, cognitive dysfunction is also a major component of depression and anxiety disorders, and may in fact underlie many of the affective symptoms (Anisman and Matheson, 2005; Beck, 1976; Coles and Heimberg, 2002; Mathews and Mackintosh, 1998).”
BackgroundMolecular characterization of the dopamine transporter
Giros, B., & Caron, M. G. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90029-j · Cited by 562 · cited 1×
“Clearance of neurotransmitter from the synapse by presynaptic transporters is the primary mechanism by which the postsynaptic effects of neurotransmitter release are terminated (Giros and Caron, 1993; see Mason et al, 2005; Miller et al, 1999).”
BackgroundDias, R., Robbins, T. W., & Roberts, A. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09285.1997 · Cited by 555 · cited 1×
“In primates, the medial prefrontal cortex (mPFC) mediates the ability to shift attention between perceptual features of complex stimuli (Dias et al, 1996, 1997; Owen et al, 1991), and in rats, it has been implicated specifically in attentional set-shifting, or the ability to ‘unlearn’ an…”
BackgroundRagozzino, M. E., Detrick, S., & Kesner, R. P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04585.1999 · Cited by 553 · cited 1×
“…to attend to changes in the environment and adapt behavioral response strategies accordingly, that is, behavioral flexibility (Dalley et al, 2004; Ragozzino et al, 1999), and several tests have been developed to measure this cognitive ability in both humans and animals (Birrell and Brown, 2000;…”
BackgroundRogers, M. A., Kasai, K., Koji, M., Fukuda, R., Iwanami, A., Nakagome, K., Fukuda, M., & Kato, N. (2004) · Neuroscience Research · doi:10.1016/j.neures.2004.05.003 · Cited by 489 · cited 2×
“Imaging studies have shown associations between cognitive dysfunction and altered activity in prefrontal cortex in depression (Rogers et al, 2004; Sheline, 2003).”
BackgroundDias, R., Robbins, T. W., & Roberts, A. C. (1996) · Behavioral Neuroscience · doi:10.1037/0735-7044.110.5.872 · Cited by 476 · cited 4×
“…in the environment and adapt behavioral response strategies accordingly, that is, behavioral flexibility (Dalley et al, 2004; Ragozzino et al, 1999), and several tests have been developed to measure this cognitive ability in both humans and animals (Birrell and Brown, 2000; Dias et al, 1996).”
BackgroundInfluentialDepression and learned helplessness.
Seligman, M. E. P. (1974) · Cited by 431
Tunbridge, E. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1124-04.2004 · Cited by 418 · cited 1×
“The difficulty of this task is reflected in the consistently higher number of trials required to reach criterion, evident both in this study and in previous studies (Birrell and Brown, 2000; Lapiz and Morilak, 2006; McAlonan and Brown, 2003; Tunbridge et al, 2004).”
ResultLocus coeruleus and regulation of behavioral flexibility and attention
(2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26013-5 · Cited by 400 · cited 3×
“At higher levels of tonic NA activity, response accuracy was reduced, and phasic activation of NA neurons by target stimuli was masked by the higher levels of tonic activity (Aston-Jones et al, 1994, 1999, 2000).”
BackgroundMethodDopamine transporters and neuronal injury
Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 371 · cited 1×
“Clearance of neurotransmitter from the synapse by presynaptic transporters is the primary mechanism by which the postsynaptic effects of neurotransmitter release are terminated (Giros and Caron, 1993; see Mason et al, 2005; Miller et al, 1999).”
BackgroundMacLeod, C., & Hagan, R. (1992) · Behaviour Research and Therapy · doi:10.1016/0005-7967(92)90138-7 · Cited by 355 · cited 1×
“It has been suggested that a perseverative attention to perceived threats, themes of loss, personal deficiency, worthlessness, or hopelessness may contribute to a vulnerability to develop affective disorders (Coles and Heimberg, 2002; MacLeod and Hagan, 1992).”
BackgroundLapiz, M. D. S., & Morilak, D. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.031 · Cited by 325 · cited 12×
“…by systemic administration of atipamezole, an a2-autoreceptor antagonist, improved performance on the ED set-shifting task, and this improvement was blocked specifically by local microinjection of a postsynaptic a1-adrenergic receptor antagonist directly into mPFC (Lapiz and Morilak, 2006).”
BackgroundMethodResultInfluentialSelf-citationMemory biases in the anxiety disorders
Coles, M. E., & Heimberg, R. G. (2002) · Clinical Psychology Review · doi:10.1016/s0272-7358(01)00113-1 · Cited by 319 · cited 4×
“It is increasingly recognized that in addition to mood symptoms, cognitive dysfunction is also a major component of depression and anxiety disorders, and may in fact underlie many of the affective symptoms (Anisman and Matheson, 2005; Beck, 1976; Coles and Heimberg, 2002; Mathews and Mackintosh, 1998).”
BackgroundInfluentialRole of norepinephrine in the pathophysiology and treatment of mood disorders
Ressler, K. J., & Nemeroff, C. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00127-4 · Cited by 307 · cited 2×
“Although their pharmacological effects on transporter function are immediate (Nestler, 1998; Ressler and Nemeroff, 1999), detectable improvements in either global symptomatology or in specific symptoms becomes evident after at least 7–14 days of treatment, whereas significant clinical improvement occurs only after sev…”
BackgroundMURPHY, F. C., MICHAEL, A., ROBBINS, T. W., & SAHAKIAN, B. J. (2003) · Psychological Medicine · doi:10.1017/s0033291702007018 · Cited by 298 · cited 2×
“This is consistent with the perseverative attention to themes of loss and worthlessness and the persistent ruminations that are prevalent in this disorder (Murphy et al, 1999, 2003).”
BackgroundExecutive functioning in obsessive-compulsive disorder, unipolar depression, and schizophrenia
Moritz, S., Birkner, C., Kloss, M., Jahn, H., Hand, I., Haasen, C., & Krausz, M. (2002) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/17.5.477 · Cited by 269 · cited 1×
“…performance on the WCST was seen in patients with lesions of the dorsolateral prefrontal cortex (Stuss et al, 2000), and in patients suffering from a variety of neuropsychiatric disorders in which mPFC dysfunction has been implicated (Fossati et al, 1999; Goldstein et al, 2002; Moritz et al, 2002).”
BackgroundMorilak, D. A., & Frazer, A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004080 · Cited by 252 · cited 4×
“…noradrenergic (NA) neurotransmission are important in the actions of many antidepressant drugs (ADs), particularly the older class of tricyclic ADs and the newer class of dual uptake inhibitors (Delgado and Moreno, 2000; Frazer, 2000, 2001; Gorman and Sullivan, 2000; Morilak and Frazer, 2004).”
BackgroundInfluentialSelf-citationKatz, M. M., Tekell, J. L., Bowden, C. L., Brannan, S., Houston, J. P., Berman, N., & Frazer, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300341 · Cited by 252
Role of norepinephrine in depression.
Delgado, P. L., & Moreno, F. A. (2000) · PubMed · Cited by 251
Executive functioning and verbal memory in young patients with unipolar depression and schizophrenia
Fossati, P., Amar, G., Raoux, N., Ergis, A. M., & Allilaire, J. F. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00110-9 · Cited by 238 · cited 3×
“Neuropsychological studies of depressed patients have revealed impairments in executive functions related to frontal lobe activity, for example, verbal fluency, cognitive set-shifting, behavioral flexibility, and perseveration (see Fossati et al, 1999).”
BackgroundThe involvement of orbitofrontal cerebrum in cognitive tasks
Stuss, D. T., Benson, D. F., Weir, W. S., Naeser, M. A., Lieberman, I., & Ferrill, D. (1983) · Neuropsychologia · doi:10.1016/0028-3932(83)90040-4 · Cited by 194 · cited 1×
“In addition, we also analyzed the occurrence of set loss errors, a measure adapted from the analysis of errors on the WCST as described by Stuss et al (1983, 2000).”
MethodMorgan, M. A., Schulkin, J. A., & LeDoux, J. E. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.021 · Cited by 176 · cited 1×
“Lesions of rat mPFC resulted in a state of ‘emotional perseveration’, or a failure to unlearn old contingencies in a fear-conditioning extinction paradigm (Morgan et al, 2003).”
BackgroundStefani, M. R., & Moghaddam, B. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1656-06.2006 · Cited by 169 · cited 1×
“The modest increase in NE is in contrast to a more robust increase seen recently in dopamine levels in mPFC (about 100% above baseline) during both rule-learning and setshifting tasks (Stefani and Moghaddam, 2006).”
ResultCognitive function in schizophrenic patients.
Robinson, D. S., Roberts, D. L., Smith, J. M., Stringfellow, J., Kaplita, S., Seminara, J. A., & Marcus, R. N. (1996) · PubMed · Cited by 159
Szabo, S. T., de Montigny, C., & Blier, P. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001772 · Cited by 154 · cited 1×
“…also act on presynaptic terminal autoreceptors and somatodendritic autoreceptors to inhibit acute excitability of the presynaptic neuron (Béı̈que et al, 2000; Szabo and Blier, 2001; Szabo et al, 2000; Valentino et al, 1990), further disconnecting neurotransmission from phasic presynaptic activity.”
BackgroundDelgado, P. L., Miller, H., Salomon, R. M., Licinio, J., Heninger, G. R., Gelenberg, A. J., & Charney, D. S. (1993) · PubMed · Cited by 153
Roberts, A., Robbins, T. W., Everitt, B. J., & Muir, J. L. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90241-s · Cited by 150 · cited 4×
“Each new discrimination required the subjects to attend to either the same dimension, or to switch their attention to the previously distracting dimension (an extradimensional shift, ED) (Roberts et al, 1992).”
BackgroundMethodInfluentialMemory retrieval enhancement by locus coeruleus stimulation: evidence for mediation by β-receptors
Devauges, V., & Sara, S. J. (1991) · Behavioural Brain Research · doi:10.1016/s0166-4328(05)80056-7 · Cited by 147 · cited 1×
“Moreover, elevated NA neurotransmission has been shown to facilitate a number of cognitive processes related to mPFC functioning, including vigilance, selective attention, learning, and memory (Aston-Jones et al, 1991, 1999; Dalley et al, 2004; Devauges and Sara, 1991; Dias et al, 1996).”
BackgroundPraško, J. P., Horáček, J., Záleský, R., Kopeček, M., Novák, T., Paskova, B., Skrdlantová, L., Bělohlávek, O., & Höschl, C. (2004) · PubMed · Cited by 145
Gelenberg, A. J., & Chesen, C. L. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1002 · Cited by 129 · cited 1×
“The beneficial effects of ADs are only evident after continued chronic administration, the socalled ‘therapeutic lag’ (Gelenberg and Chesen, 2000).”
BackgroundSzabo, S. T., & Blier, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01583.x · Cited by 125 · cited 2×
“…also act on presynaptic terminal autoreceptors and somatodendritic autoreceptors to inhibit acute excitability of the presynaptic neuron (Béı̈que et al, 2000; Szabo and Blier, 2001; Szabo et al, 2000; Valentino et al, 1990), further disconnecting neurotransmission from phasic presynaptic activity.”
BackgroundAntidepressant treatments in the 21st century
Nestler, E. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00095-x · Cited by 123 · cited 2×
“Although their pharmacological effects on transporter function are immediate (Nestler, 1998; Ressler and Nemeroff, 1999), detectable improvements in either global symptomatology or in specific symptoms becomes evident after at least 7–14 days of treatment, whereas significant clinical improvement occurs only after sev…”
BackgroundMason, J. N., Farmer, H., Tomlinson, I. D., Schwartz, J., Savchenko, V. L., DeFelice, L. J., Rosenthal, S. J., & Blakely, R. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.09.028 · Cited by 121 · cited 1×
“Clearance of neurotransmitter from the synapse by presynaptic transporters is the primary mechanism by which the postsynaptic effects of neurotransmitter release are terminated (Giros and Caron, 1993; see Mason et al, 2005; Miller et al, 1999).”
BackgroundFrazer, A. (2001) · PubMed · Cited by 106
Barriers to seeking treatment for major depression
Blumenthal*, R., & Endicott, J. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:6<273::aid-da3>3.0.co;2-d · Cited by 106
Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shifting
Chen, K. C., Baxter, M. G., & Rodefer, J. S. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03548.x · Cited by 97 · cited 1×
“…required to learn new discriminations using new sets of stimuli but they were also required to switch their learning strategy, shifting attention away from the previously salient stimulus dimension and attending to the previously irrelevant dimension (Chen et al, 2004; Lapiz and Morilak, 2006).”
BackgroundGoldstein, G., Minshew, N. J., Allen, D. N., & Seaton, B. E. (2002) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/17.5.461 · Cited by 95 · cited 1×
“…performance on the WCST was seen in patients with lesions of the dorsolateral prefrontal cortex (Stuss et al, 2000), and in patients suffering from a variety of neuropsychiatric disorders in which mPFC dysfunction has been implicated (Fossati et al, 1999; Goldstein et al, 2002; Moritz et al, 2002).”
BackgroundAntidepressant actions on brain noradrenergic neurons.
Valentino, R. J., Curtis, A. L., Parris, D. G., & Wehby, R. G. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13053-x · Cited by 95 · cited 1×
“…also act on presynaptic terminal autoreceptors and somatodendritic autoreceptors to inhibit acute excitability of the presynaptic neuron (Béı̈que et al, 2000; Szabo and Blier, 2001; Szabo et al, 2000; Valentino et al, 1990), further disconnecting neurotransmission from phasic presynaptic activity.”
BackgroundNorepinephrine involvement in antidepressant action.
Frazer, A. (2000) · PubMed · Cited by 89
Béïque, J.-C., de Montigny, C., Blier, P., & Debonnel, G. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00017-4 · Cited by 74 · cited 1×
“…will also act on presynaptic terminal autoreceptors and somatodendritic autoreceptors to inhibit acute excitability of the presynaptic neuron (Béı̈que et al, 2000; Szabo and Blier, 2001; Szabo et al, 2000; Valentino et al, 1990), further disconnecting neurotransmission from phasic…”
BackgroundKatz, M. M., Koslow, S. H., & Frazer, A. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:6<257::aid-da1>3.0.co;2-9 · Cited by 74 · cited 1×
“…or in specific symptoms becomes evident after at least 7–14 days of treatment, whereas significant clinical improvement occurs only after several weeks of treatment, and more complete recovery can take many months (Blier and de Montigny, 1994; Frazer, 1994; Katz et al, 1996/1997, 2004).”
BackgroundEffects of α-Methyl-Para-Tyrosine (AMPT) in Drug-Free Depressed Patients
Miller, H. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00072-l · Cited by 65 · cited 1×
“Acute depletion of catecholamines by administration of a-methylparatyrosine, a selective inhibitor of tyrosine hydroxylase, transiently reversed the antidepressant response in patients treated with DMI, mazindol, or mirtazapine (Delgado et al, 1983, 2002; Miller et al, 1996).”
BackgroundNoradrenergic approaches to antidepressant therapy.
Gorman, J. M., & Sullivan, G. M. (2000) · PubMed · Cited by 38
Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients
Delgado, P. L., Moreno, F. A., Onate, L., & Gelenberg, A. J. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002778 · Cited by 35 · cited 1×
“Acute depletion of catecholamines by administration of a-methylparatyrosine, a selective inhibitor of tyrosine hydroxylase, transiently reversed the antidepressant response in patients treated with DMI, mazindol, or mirtazapine (Delgado et al, 1983, 2002; Miller et al, 1996).”
BackgroundGarcia, A. S., Barrera, G., Burke, T. F., Ma, S., Hensler, J. G., & Morilak, D. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02748.x · Cited by 35 · cited 2×
“In a previous study, we found this dose of DMI to produce plasma levels comparable to those obtained with the chronic drug treatment employed in Experiment 2 (see Garcia et al, 2004).”
BackgroundResultSelf-citationFrazer, A. (1994) · Depression · doi:10.1002/depr.3050020102 · Cited by 23
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957
“Lapiz et al. (2007) described a similar improvement in set shifting following a regimen of subchronic treatment with the NE-reuptake blocker desipramine, leading to an upregulation of mPFC NE (as confirmed with microdialysis).”
BackgroundLogue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
“In normal monkeys and rats, improvements in set-shifting were produced with systemic administration of drugs that increase synaptic levels of NE, methylphenidate, desipramine, and atomoxetine (Lapiz et al. 2007; Seu and Jentsch 2009; Verrico et al. 2008).”
BackgroundJepma, M., & Nieuwenhuis, S. (2011) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2010.21548 · Cited by 439
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation
Kehagia, A. A., Murray, G. K., & Robbins, T. W. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.01.007 · Cited by 398
“followed this up with a demonstration of attentional set-shifting benefits following chronic administration of desipramine, a selective NA reuptake inhibitor [41].”
Background
Metadata
- Authors
- Lapiz, M. D. S., Bondi, C. O., & Morilak, D. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Morilak, David A
- Venue
- Neuropsychopharmacology
- Published
- 2006-11-01
- Volume
- 32
- Issue
- 5
- Pages
- 1000-1010
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2031934728
- Cited by
- 95
- References
- 69
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 8 · 2016: 4 · 2015: 4 · 2014: 2 · 2013: 7 · 2012: 6
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health (MH53851)
- National Institute of Mental Health (MH 53851, R01MH072672, MH72672)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- desipramine, noradrenergic neurotransmission, medial prefrontal cortex, set-shifting, cognitive flexibility, depression, chronic drug administration, microdialysis
- MeSH terms
- Animals, Attention, Cognition, Cognition Disorders, Depressive Disorder, Desipramine, Drug Administration Schedule, Male, Neural Pathways, Neuropsychological Tests, Norepinephrine, Set, Psychology, Rats, Sprague-Dawley, Prefrontal Cortex, Microdialysis, Adrenergic Uptake Inhibitors, Extracellular Fluid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.